Today's Reuters Health News Headlines - Yahoo! News:
|
|
Crucial vote nears in Boeing contract talks
Sat,29 Sep 2012 09:17 AM PDT
Reuters -  SEATTLE (Reuters) - One of Boeing's chief labor unions staged rallies in and around Seattle this week, calling attention to a vote set for Monday that will show whether workers are willing to accept a less generous contract offered by Boeing Co or move closer to a strike. Hundreds of engineers and technicians marched at the company's two plants, its downtown Seattle office and other facilities with signs saying "Boeing: Hands Off My Healthcare" and "We Delivered. ...
Full Story | Top |
Exclusive: North Korea plans agriculture reforms - source
Sat,29 Sep 2012 03:47 AM PDT
Reuters - BEIJING (Reuters) - North Korea plans to allow farmers to keep more of their produce in an attempt to boost agricultural output, a source with close ties to Pyongyang and Beijing said, in a move that could boost supplies, help cap rising food prices and ease malnutrition. The move to liberalize agriculture under new leader Kim Jong-un, who took office in December 2011 after the death of his father, would reverse a crackdown on private production that started in 2005. It comes amid talk that the youngest Kim to rule the impoverished North is considering reforms to boost the economy. ... Full Story | Top |
Ariad lung cancer drug shrinks tumors in small trial
Sat,29 Sep 2012 02:24 AM PDT
Reuters - (Reuters) - A small early-stage trial of Ariad Pharmaceuticals Inc's experimental pill AP26113 showed it shrank tumors in eight out of 11 lung cancer patients with a genetic mutation in a gene known as ALK. The drug, called '113 for short, is being tested in patients with non-small cell lung cancer who test positive for the abnormal ALK gene, as well as those with a specific mutation in a gene known as EGFR. Thirty-four patients have been enrolled in the Phase 1/2 trial, which is designed to determine the ideal dosage for later-stage trials. ... Full Story | Top |
Ann Romney: biggest fear is for Mitt's "mental well-being"
Fri,28 Sep 2012 05:08 PM PDT
Reuters -  WASHINGTON (Reuters) - Ann Romney told a Nevada television station her biggest concern if her husband, Republican presidential candidate Mitt Romney, becomes president was his "mental well-being." In an interview Thursday with television station KTVN, Mrs. Romney was asked what her biggest worry was should Mitt Romney be elected to serve in the White House. "I think my biggest concern obviously would just be for his mental well-being," she said. "I have all the confidence in the world in his ability, in his decisiveness, in his leadership skills, in his understanding of the economy. ... ...
Full Story | Top |
Study finds birth defects down among IVF babies
Fri,28 Sep 2012 03:36 PM PDT
Reuters - NEW YORK (Reuters Health) - Though assisted-reproduction techniques (ART) are known to come with a higher risk for birth defects, a new review of defect rates in Western Australia shows major birth defects becoming less common over the course of a decade among babies born through ART. It's unclear why there have been fewer birth defects in more recent years. ... Full Story | Top |
FDA approves Boston Scientific's unique heart device
Fri,28 Sep 2012 02:26 PM PDT
Reuters - (Reuters) - U.S. health regulators approved Boston Scientific Corp's first-of-its-kind heart defibrillator that does not require leads to be inserted into the heart. Defibrillators help control heart rhythm by applying an electric shock to the heart when it beats abnormally fast, reducing the risk of cardiac arrest. Traditional defibrillators require electrical conductor wires or leads to be inserted into the heart through a vein in the upper chest. ... Full Story | Top |
Cardiac arrests at school usually not in students
Fri,28 Sep 2012 01:53 PM PDT
Reuters - NEW YORK (Reuters Health) - Student athletes collapsing from cardiac arrest in the middle of a game may grab headlines, but when someone's heart gives up at a school, it's usually not a youngster's. In a new five-year study, researchers from Michigan found that only two out of 47 cardiac arrests at K-12 schools occurred during sports events. In fact, as many as a third of cases happened after 5 pm and mostly in adults. "Schools are community-gathering places, and two-thirds of our cases were adults," said Dr. ... Full Story | Top |
Aetna expands coverage of Dendreon drug; stock jumps
Fri,28 Sep 2012 12:49 PM PDT
Reuters - (Reuters) - Health insurer Aetna Inc said on Friday it will pay for a greater number of patients to receive Provenge, the prostate cancer drug made by Dendreon Corp, sending Dendreon's shares up as much as 10 percent. Aetna will now provide coverage for patients with metastatic prostate cancer who have failed to respond to hormone therapy and whose disease has spread to the lungs or the brain. Previously, patients whose cancer spread to the brain or lungs were not covered. Patients whose disease has spread to the liver still are not covered. ... Full Story | Top |
Sex problems common with breast cancer drugs
Fri,28 Sep 2012 12:27 PM PDT
Reuters - NEW YORK (Reuters Health) - Women treated with hormone-blocking drugs to stave off breast cancer recurrences are often dissatisfied with their sex lives, a new study from Sweden has found. More than half of older women treated with so-called aromatase inhibitors said sex was almost always painful and they frequently had "insufficient lubrication," researchers reported in the journal Menopause. In contrast, less than one-third of women on tamoxifen, another anti-estrogen drug, reported painful sex. ... Full Story | Top |
FDA approves Abbott's Humira for ulcerative colitis
Fri,28 Sep 2012 11:36 AM PDT
Reuters - (Reuters) - U.S. health regulators on Friday approved Abbott Laboratories Inc's blockbuster rheumatoid arthritis drug Humira for the treatment of moderate to severe ulcerative colitis, a form of inflammatory bowel disease. The U.S. Food and Drug Administration approved Humira for use by adults to help control the chronic condition once immunosuppressant medicines, such as corticosteroids, have proved ineffective. Humira, by far Abbott's biggest product with annual sales of about $8 billion and still growing, is already approved to treat a number of inflammatory diseases. ... Full Story | Top |
Thousands of German children suffer from vomit outbreak
Fri,28 Sep 2012 11:25 AM PDT
Reuters - BERLIN (Reuters) - More than 6,500 German children and teenagers have fallen ill with diarrhea and vomiting that health authorities say has likely been caused by a food-borne virus in meals delivered to schools and daycare centers. Regional health ministries and a top health research institute said youngsters from five of Germany's 16 states had been affected by the acute gastroenteritis, with the first cases registered on Tuesday. So far, those affected had not suffered any complications. ... Full Story | Top |
New virus not spreading easily between people: WHO
Fri,28 Sep 2012 10:44 AM PDT
Reuters -  LONDON (Reuters) - A new and potentially fatal virus from the same family as SARS which was discovered in a patient in London last week appears not to spread easily from person to person, the World Health Organization (WHO) said on Friday. In an update on the virus, which has so far killed a Saudi man and made a patient from Qatar critically ill, the United Nations health agency said it was working with international partners to understand the public health risk better. ...
Full Story | Top |
Probiotic for babies may not fight allergies later
Fri,28 Sep 2012 09:55 AM PDT
Reuters - NEW YORK (Reuters Health) - Kindergartners who were given "good bacteria" supplements as infants were no less likely to suffer from allergies than other kids in a new study from Australia. The findings, reported in the Journal of Allergy and Clinical Immunology, add to a mixed bag of results from research into whether probiotics can help ward off kids' allergies. Based on what's known so far, it may be that only certain probiotics are helpful for certain kids - but even then, the benefit seems "very modest," according to Dr. ... Full Story | Top |
Novo Nordisk halts development of haemophilia drug
Fri,28 Sep 2012 08:04 AM PDT
Reuters - COPENHAGEN (Reuters) - Denmark's Novo Nordisk said on Friday it would discontinue development of its haemophilia drug treatment vatreptacog alfa. The world's biggest insulin producer said in a statement the development would be discontinued after a few patients in a trial had developed anti-drug antibodies to the treatment, one patient with a potentially neutralising effect. The drug was intended to replace some of the $1.43 billion annual sales of the company's only other haemophilia drug now on the market - NovoSeven - as it comes off patent. ... Full Story | Top |
Canada temporarily shuts plant linked to tainted beef
Fri,28 Sep 2012 08:01 AM PDT
Reuters - (Reuters) - The Canadian Food Inspection Agency (CFIA) has temporarily shut a meatpacking plant linked to contaminated beef products that have sickened several people and been distributed across Canada and the United States. The operators of privately held XL Foods' plant in Brooks, Alberta have not done enough to prevent contamination by E. coli bacteria, the CFIA said on Friday. "All products currently at this plant are under CFIA detention and control," the agency said in a statement. ... Full Story | Top |
| |
|
No comments:
Post a Comment